Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 490 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ophthalmic Surgery Clear all

Conditions: Inflammation Eye Pain, Postoperative Cataract
Interventions: OCS-01, Vehicle; Drug
Lead sponsor: Oculis; Industry
Eligibility: 18 Years and older
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 25
States / cities: Chandler, Arizona • Phoenix, Arizona • Fayetteville, Arkansas + 21 more

Conditions: Glaucoma
Interventions: Water Drinking Test; Procedure
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pseudophakic Cystoid Macular Edema,, Diabetic Macular Edema
Interventions: Dexamethasone Implant; Drug
Lead sponsor: Northern California Retina Vitreous Associates; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Pain
Interventions: Vitrase (ovine hyaluronidase) Lyophilized; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cataract, Cataract (Post-operative Cataract Surgery Follow-up)
Interventions: Music and Guided Imagery, Control, Music Only; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Epiretinal Membrane
Interventions: Immediate Vitrectomy, Deferred Vitrectomy; Procedure
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 45 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 48
States / cities: Scottsdale, Arizona • Glendale, California • Huntington Beach, California + 41 more

Conditions: Graves Disease
Interventions: SSKI- Potassium Iodide; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Pars Plana Vitrectomy, Scleral Buckling, Surgical Outcomes, Infection Prophylaxis
Interventions: Not listed
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Keratoconus, Corneal Ectasia
Interventions: KXL System (15 mW/cm2), KXL System (30 mW/cm2), KXL System (45 mW/cm2), riboflavin ophthalmic solution; Device · Drug
Lead sponsor: American-European Congress of Ophthalmic Surgery; Network
Eligibility: 12 Years and older
Enrollment: 1,721 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 82
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 71 more

Conditions: Open Angle Glaucoma
Interventions: Suprachoroidal Dissection Instrument (SDI); Device
Lead sponsor: iScience Interventional Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Eyelid Diseases, Ptosis, Eyelid, Blepharoptosis, Dermatochalasis, Ectropion, Entropion, Eyelid Tumor, Skin Cancer, Eyelid, Floppy Eyelid Syndrome
Interventions: Telemedicine follow-up; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cataract
Interventions: ARGOS Biometer; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Open Angle Glaucoma
Interventions: Goniotomy, Trabecular Micro-Bypass Stent, Cataract Extraction; Procedure · Device
Lead sponsor: New World Medical, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: La Crosse, Wisconsin

Conditions: Postoperative Ocular Inflammation, Postoperative Ocular Pain
Interventions: Sham (No Treatment), TRIESENCE (triamcinolone acetonide injectable suspension); Procedure · Drug
Lead sponsor: Harrow Inc; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Glaucoma
Interventions: Triamcinolone injection, sub-tenon; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 2
States / cities: San Jose, California • Stanford, California

Conditions: Myopia, Astigmatism
Interventions: Topography Guided LASIK Surgery, Small Incision Lenticule Extraction Surgery; Device
Lead sponsor: Hoopes Vision; Other
Eligibility: 22 Years to 50 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Draper, Utah

Conditions: Inflammation
Interventions: Difluprednate, Placebo; Drug · Other
Lead sponsor: Sirion Therapeutics, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Pain, Inflammation
Interventions: Nepafenac PPDS, Placebo PPDS; Combination Product
Lead sponsor: Mati Therapeutics Inc.; Industry
Eligibility: 22 Years to 99 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 3
States / cities: Edgewood, Kentucky • Garden City, New York • Mt. Pleasant, South Carolina

Conditions: Dry Eye Syndromes
Interventions: Optive; Drug
Lead sponsor: Innovative Medical; Industry
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Fullerton, California

Conditions: Corneal Diseases, Retinal Diseases, Ocular Diseases
Interventions: 4D MIOCT integrated into a Zeiss Artevo 800; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Anxiety
Interventions: CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM, MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY, NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED; Device · Drug · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 50 Years to 90 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cataract
Interventions: Topical phenylephrine 2.5%, Topical cyclopentolate 1%, Intracameral Lidocaine 1%, Intracameral 0.2- 0.3ml of epinephrine 1:10,000; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cataract, Surgery, Compliance, Patient, Compliance, Medication, Satisfaction, Patient
Interventions: Dropless Regimen, Standard Regimen; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cataract
Interventions: Dexamethasone Phosphate Ophthalmic, 100 mM Sodium Citrate Buffer; Drug
Lead sponsor: Eyegate Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 3
States / cities: Miami, Florida • Tamarac, Florida • Washington, Missouri

Search by objective public record fields.

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Comparing the Effect of the Water Drinking Test on Intraocular Pressure

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Randomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?

Necessity of Post-operative Eye Drops

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Surgical Treatment of Refractory Open Angle Glaucoma

Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery

Refractive and Visual Outcomes With the ARGOS Biometer In Eyes With a History of Refractive Surgery: ARGOS Study

A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extraction

A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic Surgery

Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery

Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract

Refractive Surgery and Optive Compatibility Study

4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800

Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety

Optimal Method for Mydriasis in Cataract Surgery

Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL